Calliditas Reports Results from P-IIb (TRANSFORM) Study of Setanaxib for Treating Primary Biliary Cholangitis
Shots: Calliditas reported topline results from P-IIb (TRANSFORM) study assessing...
Merck Reports the P-IIb/III Study Data of Clesrovimab (MK-1654) to Prevent RSV Disease in Infants
Shots: Merck has reported topline data from the P-IIb/III (
Cytoki Pharma Reports Results from the P-I Study of CK-0045 to Improve Cardiometabolic Risk Factors
Shots: Cytoki Pharma reported results from the P-Itrial assessing the safety, tole...
EDAP Reports Interim Data from P-III Trial of Robotic HIFU for Treating Deep Infiltrating Endometriosis
Shots: The P-III trial assesses acute pelvic pain levels after robotic High-Intens...
Innovent Reports Data from the P-III (DREAMS-1) Study of Mazdutide to Treat Type 2 Diabetes in Chinese Patients
Shots: The P-III (DREAMS-1) study assessed mazdutide (4mg, 6mg) vs PBO to treat T2...
